Wiskott-Aldrich Syndrome

A rare, X-linked immunodeficiency syndrome characterized by ECZEMA; LYMPHOPENIA; and, recurrent pyogenic infection. It is seen exclusively in young boys. Typically, IMMUNOGLOBULIN M levels are low and IMMUNOGLOBULIN A and IMMUNOGLOBULIN E levels are elevated. Lymphoreticular malignancies are common.

Also Known As:

Eczema-Thrombocytopenia-Immunodeficiency Syndrome; Imd2; Immunodeficiency 2; Wiskott Syndrome; Eczema Thrombocytopenia Immunodeficiency Syndrome; Eczema-Thrombocytopenia-Immunodeficiency Syndromes; Immunodeficiency 2s; Wiskott Aldrich Syndrome; Wiskott Syndromes; Aldrich Syndrome

Hemic and Lymphatic Diseases: 6
- Hematologic Diseases: 3366
  - Cytopenia: 2582
    - Leukopenia: 5826
      - Lymphopenia: 4691
        Wiskott-Aldrich Syndrome: 710
  - Hemorrhagic Disorders: 702
    - Wiskott-Aldrich Syndrome: 710
  - Blood Coagulation Disorders: 167
    - Inherited Blood Coagulation Disorders: 74
      - Wiskott-Aldrich Syndrome: 710
  - Leukocyte Disorders: 8
    - Leukopenia: 5826
      - Lymphopenia: 4691
        Wiskott-Aldrich Syndrome: 710
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Inborn Genetic Diseases: 11939
  - Primary Immunodeficiency Diseases: 1189
    - Wiskott-Aldrich Syndrome: 710
  - Inherited Blood Coagulation Disorders: 74
    - Wiskott-Aldrich Syndrome: 710
  - X-Linked Genetic Diseases: 42
    - Wiskott-Aldrich Syndrome: 710
Immune System Diseases: 4321
- Immunologic Deficiency Syndromes: 91
  - Lymphopenia: 4691
    - Wiskott-Aldrich Syndrome: 710
  - Primary Immunodeficiency Diseases: 1189
    - Wiskott-Aldrich Syndrome: 710

Angélica Vasselai Selected Research

Angélica Vasselai Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure